future health semaglutide Weight Loss Explainer: What's behind the scramble
Description
We minimize side effects through gradual dosing and provide management strategies
For instance, GLP-1RA have been tested in people with serious mental illness, who could be at a high suicidality risk, showing metabolic benefits with no increase in psychopathology or occurrence of SIS [22]
This is not a regulatory delay or a bureaucratic problem
This is the end of GLP-1 compounding as we know it Branded GLP-1 drugs are no longer in shortage
